Pulmonary Zygomycosis in a Patient with X-CGD
Keywords:
chronic granulomatous disease; cgd; immunodeficiency; primary immunodeficiency; zygomycosis; fungal pneumonia
Abstract
Abstract not found
Downloads
How to Cite
References
Jw; Leiding, S Holland Chronic Granulomatous Disease [Internet.
J Winkelstein, M Marino, R Johnston, J Boyle, J Curnutte, J Gallin (2000) Chronic Granulomatous Disease: Report on a National Registry of 368 Patients. 79(3), 155-169.
F Filippin, L Souza (2006) Eficiência terapêutica das formulações lipídicas de anfotericina B. 42(2), 167-194.
T Rogers (2008) Treatment of zygomycosis: current and new options. 61(Supplement 1), i35-i40.
Methee Chayakulkeeree, M Ghannoum, J Perfect (2006) Zygomycosis: the re-emerging fungal infection. 25(4), 215-229.
Fyw Lee, S Mossad, K Adal (1999) Pulmonary Mucormycosis. (12), 1301.
Cecília Severo, Luciana Guazzelli, Luiz Severo (2010) Capítulo 7 - Zigomicose. 36(1), 134-141.
Joandes Fonteque, Mere Saito, Priscila Rizelo, William Teixeira, Aguemi Kohayagawa (2015) Comparação entre duas metodologias para a realização do teste de redução do tetrazólio nitroazul (NBT) em caprinos. 35(suppl 1), 1-4.
Dimitrios Kontoyiannis, Russell Lewis (2010) Agents of Mucormycosis and Entomophthoramycosis. 3257-3269.
Douglas Mandell, Bennett (2015) s Principles and Practice of Infectious Diseases. 69, 2909-2919.
T Kuijpers, R Lutter (2011) Inflammation and repeated infections in CGD: two sides of a coin. 69(1), 7-15.
N Rider, M Jameson, C Creech (2018) Chronic Granulomatous Disease: Epidemiology, Pathophysiology, and Genetic Basis of Disease.
G Cox (2007) Gastric Zygomycosis (Mucormycosis). 5(2).
C Kauffman, K Hall (2021) Up To Date.
(2017) SAJS Volume 120 Issue 9/10: van Breda et al. Supplementary Material. tradução.
Christof Meischl, Dirk Roos (1998) The molecular basis of chronic granulomatous disease. 19(4), 417-434.
Published
2024-08-16
Issue
Section
License
Copyright (c) 2024 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.